Cost-effectiveness of screening for HIV [4] (multiple letters)

New England Journal of Medicine

Volumn 352, Issue 20, 2005, Pages 2137-2139

  Taiwo, Babafemi O ^a   Thrasher, Angela D ^b   Ford, Chandra L ^b   Nearing, Kathryn A ^c   Da Silveira, Eduardo ^d   Sanders, Gillian D ^e   Bayoumi, Ahmed M ^f   Owens, Douglas K ^g   Paltiel, A David ^h   Walensky, Rochelle P ⁱ   Freedberg, Kenneth A ⁱ  

^a NORTHWESTERN UNIVERSITY   (United States)

^b IL   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d MCGILL UNIVERSITY   (Canada)

^e DUKE UNIVERSITY   (United States)

^f ST MICHAEL'S HOSPITAL   (Canada)

^g VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^h YALE UNIVERSITY   (United States)

ⁱ MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COST EFFECTIVENESS ANALYSIS; HEALTH EDUCATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; LETTER; LIFE EXPECTANCY; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; VIRUS TRANSMISSION; COST BENEFIT ANALYSIS; ECONOMICS; MASS SCREENING; METHODOLOGY; NOTE; QUALITY ADJUSTED LIFE YEAR; REPRODUCIBILITY; HEALTH CARE DELIVERY; HEALTH CARE POLICY; PSYCHOLOGICAL ASPECT; SOCIAL PSYCHOLOGY; UNITED STATES; COUNSELING; DISEASE TRANSMISSION; HIGH RISK BEHAVIOR;

COST-BENEFIT ANALYSIS; HIV INFECTIONS; HUMANS; LIFE EXPECTANCY; MASS SCREENING; QUALITY-ADJUSTED LIFE YEARS; REPRODUCIBILITY OF RESULTS; HEALTH POLICY; HEALTH SERVICES ACCESSIBILITY; PREJUDICE; UNITED STATES; COUNSELING; DISEASE TRANSMISSION; RISK-TAKING;

EID: 20544463886     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200505193522020     Document Type: Letter

References (0)